Paul Dickman serves as Executive at Medicine Man Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Paul Dickman has executed 14 insider transactions totaling $469.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 14, 2025 involved transacting 50,000 shares valued at $0.
Paul Dickman currently holds 22,015 shares of Medicine Man Technologies, Inc. (MDCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Dickman has been a net seller of MDCL stock. They have purchased $0 and sold $469.7K worth of shares.
Paul Dickman's most recent insider trade was on Nov 14, 2025, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 19, 2019 | MDCL | $19.9K | Sale | 5,090 | $3.91 | Discretionary |
| Jun 18, 2019 | MDCL | $291.9K | Sale | 74,465 | $3.92 | Discretionary |
| Jun 17, 2019 | MDCL | $40.3K | Sale | 10,192 | $3.95 | Discretionary |
| Jan 3, 2018 | MDCL | $197.8K | Award | 136,400 | $1.45 | Discretionary |
| Dec 29, 2017 | MDCL | $6.2K | Sale | 2,808 | $2.22 | Discretionary |
| Dec 29, 2017 | MDCL | $6.2K | Sale | 2,808 | $2.22 | Discretionary |
| Dec 28, 2017 | MDCL | $52.6K | Sale | 23,792 | $2.21 | Discretionary |
| Dec 28, 2017 | MDCL | $52.6K | Sale | 23,792 | $2.21 | Discretionary |
| Nov 1, 2017 | CIIX | $0 | Purchase | 200,000 | $N/A | Discretionary |
| Jun 7, 2017 | MDCL | $116.3K | Award | 125,000 | $0.93 | Discretionary |
| Jun 3, 2017 | MDCL | $116.3K | Award | 125,000 | $0.93 | Discretionary |
| Oct 22, 2016 | CIIX | $0 | Purchase | 100,000 | $N/A | Discretionary |